Age-related variations in follicular apolipoproteins may influence human oocyte maturation and fertility potential

Fertility and Sterility

Volumn 93, Issue 7, 2010, Pages 2354-2361

  Von Wald, Tiffany ^a,b   Monisova, Yevgeniya ^a   Hacker, Michele R ^a   Yoo, Sang Wook ^a   Penzias, Alan S ^a,b   Reindollar, Richard R ^c   Usheva, Anny ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON IVF   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Apolipoprotein; HDL; Human follicular fluid; Human oocyte maturation; IDL; In vitro fertilization; LDL; Lipoprotein particles; VLDL

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CD3 ANTIGEN; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; MULTIPROTEIN COMPLEX; PEPTIDE;

ADULT; AGE; AGING; ARTICLE; CELL COUNT; CONCENTRATION (PARAMETERS); EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HUMAN; MALE INFERTILITY; NORMAL HUMAN; OOCYTE DONATION; OOCYTE MATURATION; OVARY FOLLICLE FLUID; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTION; UTERUS DISEASE; ADOLESCENT; BLOOD; CHEMISTRY; COMPARATIVE STUDY; FERTILITY; INFERTILITY; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; OOCYTE; OOCYTE DEVELOPMENT; OVULATION INDUCTION; PHYSIOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGING; APOLIPOPROTEINS; FEMALE; FERTILITY; FOLLICULAR FLUID; HUMANS; INFERTILITY; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR WEIGHT; MULTIPROTEIN COMPLEXES; OOCYTES; OOGENESIS; OVULATION INDUCTION; PEPTIDES; YOUNG ADULT;

EID: 77952557296     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.12.129     Document Type: Article

References (26)

1. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992 Nov;7:1342-6.
2. Angelucci S, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M, Tiboni GM, et al. Proteome analysis of human follicular fluid. Biochim Biophys Acta 2006 Nov;1764:1775-85.
3. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008 Feb;93:470-6.
4. Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, et al. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretinas biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiol Biomarkers Prev 2006 Sep;15: 1641-6.
5. von Otte S, Paletta JR, Becker S, Konig S, Fobker M, Greb RR, et al. Fol-licular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 2006 Mar 3;281:5398-405.
6. Kontush A, Therond P, Zerrad A, Couturier M, Negre-Salvayre A, de Souza JA, et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 2007 Aug;27:1843-9.
7. Yesilaltay A, Morales MG, Amigo L, Zanlungo S, Rigotti A, Karackattu SL, et al. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology 2006 Apr;147:1577-88.
8. Argov N, Sklan D, Arieli A. Role for LDL in estradiol-synthesis capacity of bovine ovarian follicles. Livestock Science 2007;107:289-93.
9. Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 1996 May;81:1946-51.
10. Gu S, Chen J, Dobos KM, Bradbury EM, Belisle JT, Chen X. Comprehensive proteomic profiling of the membrane constituents of a Myco-bacterium tuberculosis strain. Mol Cell Proteomics 2003 Dec;2: 1284-96.
11. Warnick GR, McNamara JR, Boggess CN, Clendenen F, Williams PT, Landolt CC. Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses. Clin Lab Med 2006 Dec;26:803-46.
12. Chung BH, Segrest JP, Cone JT, Pfau J, Geer JC, Duncan LA. High resolution plasma lipoprotein cholesterol profiles by a rapid, high volume semi-automated method. J Lipid Res 1981 Aug;22:1003-14.
13. Choi CH, Hiromura M, Usheva A. Transcription factor IIB acetylates itself to regulate transcription. Nature 2003 Aug 21;424:965-9.
14. Ordovas JM. Lipoprotein protocols. Totowa, NJ: Human Press Inc., 2008.
15. Petkova V, Romanowski MJ, Sulijoadikusumo I, Rohne D, Kang P, Shenk T, et al. Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in differentiated cells. J Biol Chem 2001 Mar 16;276:7932-6.
16. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, et al. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod 2007 Sep;22: 2455-62.
17. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2005 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta, Georgia: Centers for Disease Control and Prevention; 2007.
18. Brown SA, Hay RV, Schreiber JR. Relationship between serum estrogen and level of apolipoprotein E in human ovarian follicular fluid. Fertil Steril 1989 Apr;51:639-43.
19. Simpson ER, Rochelle DB, Carr BR, MacDonald PC. Plasma lipopro-teins in follicular fluid of human ovaries. J Clin Endocrinol Metab 1980 Dec;51:1469-71.
20. Jaspard B, Fournier N, Vieitez G, Atger V, Barbaras R, Vieu C, et al. Structural and functional comparison of HDL from homologous human plasma and follicular fluid. A model for extravascular fluid. Arterioscler Thromb Vasc Biol 1997 Aug;17:1605-13.
21. Sacks FM. The apolipoprotein story. Atheroscler Suppl 2006 Aug;7: 23-7.
22. Driscoll DM, Getz GS. Extrahepatic synthesis of apolipoprotein E. J Lipid Res 1984 Dec 1;25:1368-79.
23. Dyer CA, Curtiss LK. Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J Biol Chem 1988 Aug 5;263: 10965-73.
24. Berneis K, Rizzo M. LDL size: does it matter? Swiss Med Wkly 2004 Dec 18;134:720-4.
25. Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol 2006 Feb 15;107:166-70.
26. Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 2004 Jul;19:1544-7.